FTC sues to block $28B Amgen-Horizon deal, in move that will send shockwaves through biopharma M&A
The FTC on Tuesday filed a lawsuit to block Amgen’s proposed $28 billion buyout of Horizon Therapeutics, a move that Wall …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
